In a groundbreaking move, President Trump has forged agreements with major pharmaceutical companies to significantly lower drug prices for Americans, ensuring access to affordable medications for chronic conditions.
Discover the hidden details of your privacy rights as outlined in the terms of use from FOX News. This article uncovers essential information that every user should know to protect their data.
The IAEA reports that the protective shield at Chernobyl has been severely damaged by a drone strike, raising serious concerns about nuclear safety and containment of radioactive waste. Urgent renovations are needed to prevent further degradation.
A massive missile attack by Russia on Kyiv has left the city in chaos, disrupting power and water services. Residents are urged to take shelter as Ukrainian officials warn of ongoing threats. This follows a weekend peace negotiation attempt.
In a recent Fox News interview, Trump argues that while foreign workers are essential for certain industries, his administration's immigration policies could harm the U.S. economy. Experts raise concerns over the $100,000 H-1B visa fee and its impact on startups.
In a recent Fox News interview, President Trump reaffirmed the importance of H-1B visas, arguing that the U.S. lacks certain talents. His comments spark debate on immigration and job displacement amid economic growth.
The Xbox Ally impresses with its out-of-the-box experience, especially for Xbox ecosystem users. However, it requires significant polish. Discover the exciting updates coming through 2026 and how they will enhance your gaming experience!
With the fantasy football playoffs approaching, discover the must-start players and those to avoid in Week 10. Key insights on quarterbacks, running backs, receivers, and tight ends that could make or break your season!
The U.S. faces its longest government shutdown, impacting millions of federal workers and essential programs like SNAP and Head Start. As Thanksgiving approaches, air travel chaos looms if the deadlock continues.
In a groundbreaking move, the Trump administration has announced new agreements with Novo Nordisk and Eli Lilly to significantly reduce the cost of GLP-1 medications for American patients, including those on Medicare. With prices set to drop dramatically, millions will soon benefit from affordable access to essential treatments.